HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Osteochondroma

Osteochondroma is a relatively common benign bone tumor characterized by the overgrowth of cartilage and bone near the end of a long bone. It typically manifests during adolescence or early adulthood and is considered a non-cancerous, slow-growing lesion. Osteochondromas are often asymptomatic and may go unnoticed until discovered incidentally during imaging studies for unrelated issues. The exact cause of osteochondroma is not well understood, but it is generally believed to result from a genetic mutation. These tumors most commonly affect the metaphysis of long bones, such as the femur or tibia, and are often found near the growth plates. While the majority of cases involve a solitary lesion, some individuals may develop multiple osteochondromas, a condition known as multiple hereditary exostoses. Clinical evaluation involves physical examination, imaging studies like X-rays, and, in some cases, advanced imaging techniques such as MRI or CT scans. Treatment is usually unnecessary unless the tumor causes pain, impairs joint function, or leads to other complications. Surgical removal may be considered in such cases, with the procedure aimed at eliminating symptoms and preventing potential complications. Prognosis for individuals with osteochondroma is generally favorable. The condition rarely transforms into malignancy, and most people can lead normal, healthy lives with minimal impact on their daily activities. Regular monitoring and medical follow-ups are recommended to ensure early detection of any potential issues and to address them promptly if they arise.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp